Centiva Capital’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-221,300
Closed -$2.22M 1859
2022
Q3
$2.22M Buy
221,300
+81,090
+58% +$807K 0.04% 329
2022
Q2
$1.39M Buy
140,210
+55,266
+65% +$546K 0.03% 482
2022
Q1
$838K Buy
+84,944
New +$834K 0.02% 779

Centiva Capital's LUXA Position: Q4 2022 in Review

Centiva Capital sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 221,300 shares — an estimated $2.22M sold.

Centiva Capital first reported a position in LUXA in Q1 2022 and held it in 3 quarters. The position peaked at $2.22M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Centiva Capital reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Centiva Capital sold 221,300 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.22M.
  • Centiva Capital first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Centiva Capital's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.22M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.